» Articles » PMID: 23959938

Oxidative Stress Defines the Neuroprotective or Neurotoxic Properties of Androgens in Immortalized Female Rat Dopaminergic Neuronal Cells

Overview
Journal Endocrinology
Specialty Endocrinology
Date 2013 Aug 21
PMID 23959938
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Males have a higher risk for developing Parkinson's disease and parkinsonism after ischemic stroke than females. Although estrogens have been shown to play a neuroprotective role in Parkinson's disease, there is little information on androgens' actions on dopamine neurons. In this study, we examined the effects of androgens under conditions of oxidative stress to determine whether androgens play a neuroprotective or neurotoxic role in dopamine neuronal function. Mitochondrial function, cell viability, intracellular calcium levels, and mitochondrial calcium influx were examined in response to androgens under both nonoxidative and oxidative stress conditions. Briefly, N27 dopaminergic cells were exposed to the oxidative stressor, hydrogen peroxide, and physiologically relevant levels of testosterone or dihydrotestosterone, applied either before or after oxidative stress exposure. Androgens, alone, increased mitochondrial function via a calcium-dependent mechanism. Androgen pretreatment protected cells from oxidative stress-induced cell death. However, treatment with androgens after the oxidative insult increased cell death, and these effects were, in part, mediated by calcium influx into the mitochondria. Interestingly, the negative effects of androgens were not blocked by either androgen or estrogen receptor antagonists. Instead, a putative membrane-associated androgen receptor was implicated. Overall, our results indicate that androgens are neuroprotective when oxidative stress levels are minimal, but when oxidative stress levels are elevated, androgens exacerbate oxidative stress damage.

Citing Articles

Sex Differences in Parkinson's Disease: A Narrative Review.

Cattaneo C, Pagonabarraga J Neurol Ther. 2024; 14(1):57-70.

PMID: 39630386 PMC: 11762054. DOI: 10.1007/s40120-024-00687-6.


Key Nutrients for Optimal Blood Glucose Control and Mental Health in Individuals with Diabetes: A Review of the Evidence.

Basiri R, Seidu B, Cheskin L Nutrients. 2023; 15(18).

PMID: 37764713 PMC: 10536295. DOI: 10.3390/nu15183929.


Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development.

Katleba K, Ghosh P, Mudryj M Biomedicines. 2023; 11(8).

PMID: 37626712 PMC: 10452427. DOI: 10.3390/biomedicines11082215.


Sex and Brain: The Role of Sex Chromosomes and Hormones in Brain Development and Parkinson's Disease.

Terrin F, Tesoriere A, Plotegher N, Dalla Valle L Cells. 2023; 12(11).

PMID: 37296608 PMC: 10252697. DOI: 10.3390/cells12111486.


The association of vitamin D status with oxidative stress biomarkers and matrix metalloproteinases in patients with knee osteoarthritis.

Amirkhizi F, Ghoreishy S, Baker E, Hamedi-Shahraki S, Asghari S Front Nutr. 2023; 10:1101516.

PMID: 36845046 PMC: 9944738. DOI: 10.3389/fnut.2023.1101516.


References
1.
Ichas F, Jouaville L, Sidash S, Mazat J, Holmuhamedov E . Mitochondrial calcium spiking: a transduction mechanism based on calcium-induced permeability transition involved in cell calcium signalling. FEBS Lett. 1994; 348(2):211-5. DOI: 10.1016/0014-5793(94)00615-6. View

2.
Mitchell E, Thomas D, Burnet R . Testosterone improves motor function in Parkinson's disease. J Clin Neurosci. 2006; 13(1):133-6. DOI: 10.1016/j.jocn.2005.02.014. View

3.
Estrada M, Uhlen P, Ehrlich B . Ca2+ oscillations induced by testosterone enhance neurite outgrowth. J Cell Sci. 2006; 119(Pt 4):733-43. DOI: 10.1242/jcs.02775. View

4.
Guevara R, Santandreu F, Valle A, Gianotti M, Oliver J, Roca P . Sex-dependent differences in aged rat brain mitochondrial function and oxidative stress. Free Radic Biol Med. 2008; 46(2):169-75. DOI: 10.1016/j.freeradbiomed.2008.09.035. View

5.
Van Den Eeden S, Tanner C, Bernstein A, Fross R, Leimpeter A, Bloch D . Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003; 157(11):1015-22. DOI: 10.1093/aje/kwg068. View